Keywords: Heparin, USA, USP, Anti-clotting drugs

New USP standards for heparin products will result in decreased potency

Article | 02 October 2009

Print This

The US Food and Drug Administration has alerted health care professionals to a change in heparin manufacturing that is expected ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in